NMPA Approval

Mesalazine Enteric-coated Sustained-release Capsules

Approval Number

国药准字H20249598

Company北京福元医药股份有限公司

Registration Date

December 1, 2024

Drug Information

Generic Name

美沙拉嗪肠溶缓释胶囊

Dosage Form

胶囊剂

Strength

0.375g

Drug Type

化学药品

Registration Date

December 1, 2024

Company Information

Applicant Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

Manufacturing Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

美沙拉嗪肠溶缓释胶囊 - NMPA 批准文号 | MedPath